Farxiga is indicated to [Select All That Apply]:
a. improve blood sugar control along with diet and exercise in adults with type 2 diabetes.
b. reduce the risk of hospitalization for heart failure in adults with type 2 diabetes.
c. reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
d. reduce the risk of diabetic ketoacidosis in adults with type 1 diabetes.
Answer: (a,b,c)
The active ingredient found in Farxiga is Dapagliflozin (Farxiga). Farxiga is indicated to:
1. improve blood sugar control along with diet and exercise in adults with type 2 diabetes.
2. reduce the risk of hospitalization for heart failure in adults with type 2 diabetes.
3. reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
Farxiga should not be used to treat people with type 1 diabetes or diabetic ketoacidosis (increased ketones in your blood or urine).
To improve glycemic control, the recommended starting dose of Farxiga is 5 mg orally once daily, taken in the morning, with or without food. In patients tolerating Farxiga 5 mg once daily who require additional glycemic control, the dose can be increased to 10 mg once daily.
Ready for the full prep?
Continue your preparation with full NAPLEX practice questions, question bank access, and study materials.
Go to NAPLEX Study Materials